Antimicrobial Stewardship Project Newsletter

New at CIDRAP-ASP

News

Global AMR Commitments

This week, CIDRAP News reporter Chris Dall, MA, reported on commitments to tackling antimicrobial resistance (AMR) affirmed at the United Nations High-Level Interactive Dialogue on AMR and much more.
Quiz

Short-course Antibiotic Guidelines

Take our May quiz and test your knowledge on new US guidelines that recommend a short course of antibiotics for four common bacterial infections.

COVID-19 and Co-infections

Call for Applications

US CDC International Funding Opportunity

The US Centers for Disease Control and Prevention (CDC) announced an international funding opportunity to support efforts to establish two new CDC networks that will improve prevention and detection of drug-resistant infections, healthcare-associated infections, and COVID-19. Optional letters of intent are due by May 27, and applications are due by Jun 28. CDC will also hold informational webinars on May 18 and May 20.
Perspective

Scenarios for Antibiotic Use in COVID-19 Patients

In the Pharmaceutical Journal, R. Andrew Seaton, MBChB, MD, describes discrepancies between antibiotic use and indications for prescribing during the pandemic, highlighting scenarios in which antibiotic use should be considered for COVID-19 patients.
Commentary

AMR as a Long-Term Side Effect of COVID-19

On the World Bank blog, Enis Baris, MD, PhD, MSc, argues that AMR may qualify as a population-wide side effect or long-term sequela of COVID-19.

New in the Literature: COVID-19 and Co-infections

The following articles were added to the CIDRAP-ASP COVID-19 and Co-infections bibliography from Apr 29 to May 5, 2021. 

Aznar ML, Espinosa-Pereiro J, Saborit N, et al. Impact of the COVID-19 pandemic on tuberculosis management in Spain. Int J Infect Dis 2021 (published online Apr 27)

Chang CT, Lee M, Lee JCY, et al. Public KAP towards COVID-19 and antibiotics resistance: a Malaysian survey of knowledge and awareness. Int J Environ Res Public Health 2021 (pubished online Apr 9)

Cimolai N. The complexity of co-infections in the era of COVID-19. SN Compr Clin Med 2021 (published online Apr 23)

d'Humières C, Patrier J, Lortat-Jacob B, et al. Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France. PLoS One 2021 (published online Apr 29)

Mitaka H, Kuno T, Takagi H, et al. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Mycoses 2021 (published online Apr 25)

Posteraro B, De Angelis G, Menchinelli G, et al. Risk factors for mortality in adult COVID-19 patients who develop bloodstream infections mostly caused by antimicrobial-resistant organisms: analysis at a large teaching hospital in Italy. J Clin Med 2021 (published online Apr 17)

Powell N, Howard P, Llewelyn MJ, et al. Use of procalcitonin during the first wave of COVID-19 in the acute NHS hospitals: a retrospective observational study. Antibiotics 2021 May 1;10(5)

Riou C, Du Bruyn E, Stek C, et al. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis co-infection. J Clin Invest 2021 (published online May 4)

Sehgal K, Fadel HJ, Tande AJ, et al. Outcomes in patients with SARS-CoV-2 and Clostridioides difficile coinfection. Infect Drug Resist 2021 (published online Apr 28)

Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol 2021 (published online Apr 7)

CIDRAP-ASP COVID-19 and Co-infections Resource Hub

Global Policy and Projects

National Project

Aotearoa New Zealand 2021 AMR Project

Aotearoa New Zealand's Office of the Prime Minister's Chief Science Advisor Dame Juliet Gerrard, DPhil, announced progress on the 2021 project "Kotahitanga: Uniting Aotearoa against infectious diseases and antimicrobial resistance," which will provide an evidence synthesis with recommendations to mitigate the risk of drug resistance and infectious diseases for Aotearoa New Zealand.
Project

App for Antibiogram Interpretation in Low-Resource Settings

On Devex, Jenny Lei Ravelo describes an app being tested by Médecins Sans Frontières/Doctors Without Borders and laboratories in Jordan, Mali, and Senegal that uses artificial intelligence to assist laboratory technicians in interpreting antibiograms in the absence of microbiologists.
Interview

AMR Education and Advocacy

In a ReAct interview, Vanessa Carter describes how her experience with a traumatic injury and a drug-resistant infection led her to become an advocate for patient and policymaker education and empowerment on AMR.
Blog Post

Behind the Scenes of ProMED-AMR

In a Global Antibiotic Research & Development Partnership REVIVE blog post, Matthew E. Levison, MD, describes the concepts behind the recent formation of ProMED-AMR, an open-access Program for Monitoring Emerging Diseases (ProMED) network dedicated to One Health AMR surveillance and information-sharing.
Analysis

US Antibiotic Duration Limits in Animal Agriculture

The Pew Charitable Trusts released an analysis that identifies actions needed by the US Food and Drug Administration to establish duration limits for antibiotics used in animal agriculture.
Commentary

Political Economy Analyses to Enhance AMR Surveillance

In a commentary for the Fleming Fund, Nicole DeCastro, MPH, describes how the Fleming Fund uses political economy analyses in Bangladesh, Indonesia, Nigeria, and Pakistan to enhance coordination of multi-sectoral One Health AMR surveillance.

Want More CIDRAP-ASP?

  • Keep up with the latest by following @CIDRAP_ASP on Twitter. We post daily threads of what we've added to our COVID-19 and Co-infections Resource Hub.

  • We update our bibliographies every day with new resources on antimicrobial stewardship interventions, diagnostics, policy, AMR surveillance, and more. 

  • We co-produced a podcast series—"Superbugs and You"—with the Antimicrobial Resistance Fighter Coalition that features stories of resilience and innovation from patients, clinicians, and researchers experiencing and finding solutions to drug-resistant infections. You can listen to the series online or on your podcast app of choice.

  • We update our diagnostics and surveillance resource hubs weekly. Learn more about antibiograms, laboratory capacity in low- and middle-income countries, AMR surveillance across the One Health spectrum, and tools to implement AMR and antibiotic use data collection in diverse settings.

  • Are you looking for an online course, a video or infographic, a webinar recording, or another tool to educate yourself or others about AMR and antimicrobial stewardship? Check out our vast collection of educational multimedia, which is updated monthly with new resources.

CIDRAP-ASP Website

Facebook
LinkedIn
Twitter
RSS Feeds

Contact Us

Center for Infectious Disease Research and Policy
Office of the Vice President for Research, University of Minnesota, Minneapolis, MN

Copyright © 2021 Regents of the University of MN
Office of the Vice President for Research, University of MN

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.